Antidiabetic properties of the histamine H3 receptor protean agonist proxyfan

Endocrinology

Volumn 152, Issue 3, 2011, Pages 828-835

  Henry, Melanie B ^a   Zheng, Shuqin ^a   Duan, Chenxia ^a   Patel, Bhuneshwari ^a   Vassileva, Galya ^a   Sondey, Christopher ^a   Lachowicz, Jean ^a   Hwa, Joyce J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPHENIRAMINE; GLUCAGON; GLUCOSE; HISTAMINE H3 RECEPTOR AGONIST; IMETIT; INSULIN; METFORMIN; PROXYFAN; STREPTOZOCIN; THIOPERAMIDE; UNCLASSIFIED DRUG; ZOLANTIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIET RESTRICTION; DRUG ACTIVITY; GLUCOSE TOLERANCE TEST; INSULIN SENSITIVITY; LIPID DIET; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HISTAMINE AGONISTS; HYPOGLYCEMIC AGENTS; IMIDAZOLES; MALE; MICE; MICE, INBRED ICR; MICE, KNOCKOUT; PIPERIDINES; RECEPTORS, HISTAMINE H1; RECEPTORS, HISTAMINE H2; RECEPTORS, HISTAMINE H3;

EID: 79951883021     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0757     Document Type: Article

References (21)

1. Tiligada E, Zampeli E, Sander K, Stark H 2009 Histamine H3 and H4 receptors as novel drug targets. Expert Opin Investig Drugs 18:1519-1531
2. Toyota H, Dugovic C, Koehl M, Laposky AD, Weber C, Ngo K, Wu Y, Lee DH, Yanai K, Sakurai E, Watanabe T, Liu C, Chen J, Barbier AJ, Turek FW, Fung-Leung WP, Lovenberg TW 2002 Behavioral characterization of mice lacking histamine H(3) receptors. Mol Pharmacol 62:389-397 (Pubitemid 34804119)
3. Gastinger MJ, Barber AJ, Vardi N, Marshak DW 2006 Histamine receptors in mammalian retinas. J Comp Neurol 495:658-667
4. Takahashi K, Suwa H, Ishikawa T, Kotani H 2002 Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J Clin Invest 110:1791-1799 (Pubitemid 36076486)
5. Gbahou F, Rouleau A, Morisset S, Parmentier R, Crochet S, Lin JS, Ligneau X, Tardivel-Lacombe J, Stark H, Schunack W, Ganellin CR, Schwartz JC, Arrang JM 2003 Protean agonism at histamine H3 receptors in vitro and in vivo. Proc Natl Acad Sci USA 100:11086-11091 (Pubitemid 37140156)
6. Baldi E, Bucherelli C, Schunack W, Cenni G, Blandina P, Passani MB 2005 The H3 receptor protean agonist proxyfan enhances the expression of fear memory in the rat. Neuropharmacology 48:246-251 (Pubitemid 40208260)
7. Fox GB, Pan JB, Esbenshade TA, Bitner RS, Nikkel AL, Miller T, Kang CH, Bennani YL, Black LA, Faghih R, Hancock AA, Decker MW 2002 Differential in vivo effects of H3 receptor ligands in a new mouse dipsogenia model. Pharmacol Biochem Behav 72:741-750 (Pubitemid 34450873)
8. Mollet A, Lutz TA, Meier S, Riediger T, Rushing PA, Scharrer E 2001 Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin. Am J Physiol Regul Integr Comp Physiol 281:R1442-R1448
9. Yokota E, Kuyama S, Sugimoto Y, Ogawa M, Kamei C 2008 Participation of histamine H3 receptors in experimental allergic rhinitis of mice. J Pharmacol Sci 108:206-211
10. Rahman MA, Inoue T, Ishikawa T, Yatsuzuka R, Ohtsu H, Kamei C 2007 Involvement of chemical mediators in nasal allergic responses of HDC-KO mice. Eur J Pharmacol 567:245-251 (Pubitemid 46976884)
11. Abdul-Ghani MA, Tripathy D, DeFronzo RA 2006 Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130-1139 (Pubitemid 44115261)
12. Ahrén B 2000 Autonomic regulation of islet hormone secretion - implications for health and disease. Diabetologia 43:393-410 (Pubitemid 30237947)
13. Malinowska B, Godlewski G, Schlicker E 1998 Histamine H3 receptors - general characterization and their function in the cardiovascular system. J Physiol Pharmacol 49:191-211 (Pubitemid 28331405)
14. Molderings GJ, Weissenborn G, Schlicker E, Likungu J, Göthert M 1992 Inhibition of noradrenaline release from the sympathetic nerves of the human saphenous vein by presynaptic histamine H3 receptors. Naunyn Schmiedebergs Arch Pharmacol 346:46-50
15. Nowak JZ 1985 Depolarisation-evoked release of dopamine and histamine from brain tissue and studies on presynaptic dopamine-histamine interaction. Pol J Pharmacol Pharm 37:359-381
16. Racké K, Schwörer H 1991 Regulation of serotonin release from the intestinal mucosa. Pharmacol Res 23:13-25
17. Stocking EM, Letavic MA 2008 Histamine H3 antagonists as wakepromoting and pro-cognitive agents. Curr Top Med Chem 8:988-1002
18. Barocelli E, Ballabeni V 2003 Histamine in the control of gastric acid secretion: a topic review. Pharmacol Res 47:299-304
19. Blandizzi C, Tognetti M, Colucci R, Del Tacca M 2000 Histamine H(3) receptors mediate inhibition of noradrenaline release from intestinal sympathetic nerves. Br J Pharmacol 129:1387-1396 (Pubitemid 30175711)
20. Imamura M, Smith NC, Garbarg M, Levi R 1996 Histamine H3-receptor-mediated inhibition of calcitonin gene-related peptide release from cardiac C fibers. A regulatory negative-feedback loop. Circ Res 78:863-869 (Pubitemid 26131371)
21. Bosi E 2009 Metformin - the gold standard in type 2 diabetes: what does the evidence tell us? Diabetes Obes Metab 11(Suppl 2):3-8